Germany Biotechnology Market Summary, Competitive Analysis and Forecast to 2027

Germany Biotechnology Market Summary, Competitive Analysis and Forecast to 2027
Summary
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key HighlightsThe biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.The German biotechnology market had total revenues of $32.7 billion in 2022, representing a compound annual growth rate (CAGR) of 50.8% between 2017 and 2022.Medical/healthcare segment accounted for market's the largest proportion in 2022, with total revenues of $30.7 billion, equivalent to 93.8% of the market's overall value.The German biotechnology market witnessed a strong growth of 18.2% in 2022. Innovation in the biotech business continues to be a major driver.ScopeSave time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in GermanyUse the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in GermanyLeading company profiles reveal details of key biotechnology market players’ global operations and financial performanceAdd weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts by both value and volumeReasons to BuyWhat was the size of the Germany biotechnology market by value in 2022?What will be the size of the Germany biotechnology market in 2027?What factors are affecting the strength of competition in the Germany biotechnology market?How has the market performed over the last five years?Who are the top competitors in Germany's biotechnology market?